COVALON TECHNOLOGIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.11 CAD | +6.73% |
|
+4.72% | +4.72% |
| Mar. 06 | Transcript : Covalon Technologies Ltd. - Shareholder/Analyst Call | |
| Feb. 28 | Covalon Technologies Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Presenter SpeechBrian Pedlar (Executives)[Audio Gap] was $8.2 million, which is up -- which is...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalonâs name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.
Calendar
2024-05-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +4.72% | 20.13M | |
| +29.77% | 49.46B | |
| +1.00% | 42.58B | |
| +50.01% | 42.49B | |
| -5.26% | 29.09B | |
| +13.68% | 26.61B | |
| -22.99% | 18.64B | |
| +8.22% | 13.16B | |
| +32.41% | 12.55B | |
| +24.01% | 12.1B |
- Stock Market
- Equities
- COV Stock
- News Covalon Technologies Ltd.
- Transcript : Covalon Technologies Ltd., Q2 2022 Earnings Call, May 30, 2022